UBS’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$16K Sell
868
-3,232
-79% -$69.4K ﹤0.01% 8304
2014
Q2
$85K Buy
4,100
+2,611
+175% +$53.1K ﹤0.01% 6147
2014
Q1
$28K Sell
1,489
-2,415
-62% -$46.6K ﹤0.01% 7657
2013
Q4
$70K Sell
3,904
-32,737
-89% -$565K ﹤0.01% 6516
2013
Q3
$484K Sell
36,641
-323
-0.9% -$4.57K ﹤0.01% 4177
2013
Q2
$516K Buy
+36,964
New +$483K ﹤0.01% 4070

Other funds holding CBM

UBS's CBM Position: Q3 2014 in Review

UBS reduced its Cambrex Corporation (CBM) stake by 79% in Q3 2014, selling an estimated $69.4K and leaving 868 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #8304.

UBS first reported a position in CBM in Q2 2013 and has held it in 6 quarters since. The position peaked at $516K in Q2 2013. 172 funds tracked by Wall St. Rank hold CBM as of Q3 2014.

  • UBS held 868 shares of Cambrex Corporation worth $16K as of Q3 2014.
  • UBS sold 3,232 Cambrex Corporation shares in Q3 2014, an estimated $69.4K.
  • Cambrex Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8304 holding.
  • UBS first reported a position in Cambrex Corporation in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cambrex Corporation position peaked at $516K in Q2 2013.
  • 172 funds tracked by Wall St. Rank held Cambrex Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.